Global Blood Therapeutics
Financial ratios & Valuation

Historical Multiples (2013 – 2021)

2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-51.87-28.51-8.93-5.81-14.23-12.05-17.37-10.73-6.07-13.93-10.02
Price/Sales ratio
N/AN/AN/AN/AN/AN/A2.19K21.459.4519.12N/A
Price/Book Value ratio
-36.18-12.022.942.575.223.668.016.389.3737.953.89
Price/Cash Flow ratio
-63.93-29.48-13.40-7.08-17.90-15.51-23.84-12.53-7.17-18.01-16.70
Price/Free Cash Flow ratio
-60.08-29.01-12.98-6.94-17.32-14.97-23.42-12.04-7.08-17.87-16.15
Price/Earnings Growth ratio
N/A-0.34-0.060.18-1.26-0.51-0.510.92-0.310.73-0.53
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A97.72%98.39%98.29%98.10%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A-13343.59%-196.41%-147.44%-127.41%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A-12654.93%-199.95%-155.38%-136.94%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A-12654.93%-199.95%-155.63%-137.29%N/A
Effective Tax Rate
N/A1.42%-0.07%-0.79%-1.89%-4.90%-5.44%-2.19%-0.15%-0.11%-1.34%
Return on Assets
-293.51%-37.31%-30.28%-40.74%-32.80%-28.20%-33.50%-34.19%-32.27%-37.04%-30.50%
Return On Equity
69.74%42.18%-32.92%-44.26%-36.70%-30.41%-46.09%-59.48%-154.31%-170.37%-33.55%
Return on Capital Employed
-649.64%-38.54%-32.59%-44.48%-36.08%-31.29%-38.81%-37.70%-33.73%-38.49%-33.69%
Liquidity Ratios
Current Ratio
N/A21.1214.069.6512.3414.388.787.99N/A6.8713.36
Quick Ratio
0.8721.1214.069.6512.3414.388.777.488.455.8713.36
Cash ratio
0.8720.5213.845.937.558.154.226.267.782.807.85
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A456.5951.5953.9746.25N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A9.71K7.39K6.40K5.39KN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A10.16K7.44K6.46K5.40KN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A80.76K3.50K1.66K677.20N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A-70.59K3.93K4.79K699.56N/A
Debt Ratios
Debt Ratio
5.20N/AN/AN/AN/AN/A0.090.210.700.86N/A
Debt Equity Ratio
-1.23N/AN/AN/AN/AN/A0.130.363.356.35N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.110.260.760.84N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.110.260.770.84N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-24.89N/A-12.11N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A-2.57-1.37-0.38-0.37N/A
Company Equity Multiplier
-0.23-1.131.081.081.111.071.371.734.787.351.10
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A-92.22-1.71-1.31-1.06N/A
Free Cash Flow / Operating Cash Flow Ratio
1.061.011.031.011.031.031.011.041.011.001.03
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A-2.57-1.37-0.38-0.37N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-104.18-43.80-45.29-40.75N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A